致我们尊敬的客户和合作伙伴： 

To whom it may concern 

ACTAVIS IS NOT AFFECTED BY ICELAND’S FINANCIAL CRISIS阿特维斯不受冰岛金融危机影响 

In light of recent market events in the financial sector, which are a consequence of the world financial crisis, we would like to clarify the position of Actavis Group hf. And related companies in Iceland.鉴于最近冰岛因全球经济风暴而导致金融市场受影响，在此，我们重申阿特维斯集团和相关的企业在冰岛的处境。

Actavis Group hf. is not exposed to the Icelandic banks in regards to funding or normal banking facilities. Our banking operations are with international banks not exposed to the current events in . We therefore, as before, have full banking operations without restrictions, both to make payments and receive payments. 因集团正常的银行运作和资金准备，阿特维斯并没有受冰岛的银行体系影响。我们的银行运作是国际银行运作，而不是现行在冰岛内的银行体系。因此，我们并没有受到金融限制，仍像以前一样正常支付费用和接收付款。

Actavis Group hf. is a global generic pharmaceutical company with a turnover of about €1.7bn this year with only 1%of our revenues generated in . We provide high-quality , low-cost products to our customers in the US, Europe, and other major markets of the world, and are paid by them directly into our international bank accounts. Notwithstanding the challenges facing the world economy, we continue to experience rising demand and to launch new products which has driven steady increases in our sales.阿特维斯是全球性普药公司，今年其销售额约17亿欧元，在冰岛的营业收入只占1%。 我们的客户普布美国、欧洲和全球其他重要的市场，我们向顾客提供高品质、低成本的产品，并通过国际银行收支客户款项。尽管全球经济面临严重挑战，但是我们仍有着上升的市场需求，仍继续上市新产品，因此，我们的业务依然稳健上升。 

We value our relationship with your company and we would like to stress that the events in the Icelandic banking sector do not impact our normal course of business. 我们重视与贵公司的合作关系，我们将再次强调冰岛银行系统并不影响到阿特维斯正常的业务发展。

Please contact us further if you would like any clarification.如需任何声明可进一步与我们联系。